Biohaven Ltd.
(NYSE : BHVN)

( )
BHVN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.43%178.000.7%$1154.07m
LLYEli Lilly & Co. -0.92%367.001.1%$1126.70m
MRKMerck & Co., Inc. -0.57%109.200.7%$1027.30m
PFEPfizer Inc. -0.86%50.700.9%$983.27m
ABBVAbbVie, Inc. -0.37%160.991.9%$862.89m
BMYBristol-Myers Squibb Co. -0.47%80.491.1%$768.06m
AZNAstraZeneca Plc -0.72%67.851.0%$355.55m
HZNPHorizon Therapeutics Plc 2.13%103.035.4%$315.80m
IDXXIDEXX Laboratories, Inc. -2.46%428.363.9%$224.32m
CTLTCatalent, Inc. -1.63%51.391.9%$210.20m
GSKGSK Plc -0.01%35.030.3%$189.72m
NVSNovartis AG -1.36%88.590.2%$183.80m
NVONovo Nordisk A/S -0.92%124.970.1%$171.23m
ALNYAlnylam Pharmaceuticals, Inc. 0.00%220.258.0%$161.43m
RGENRepligen Corp. 0.00%188.176.7%$134.32m

Company Profile

Biohaven Ltd. operates as a biopharmaceutical company that focuses on neurological and neuropsychiatric diseases. Its portfolio includes treatments for medical needs including focal epilepsy, obsessive compulsive disorder, spinocerebellar ataxia and spinal muscular atrophy. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.